ANDREW HUANG
Osteopathic Medicine at Erwin Rd, Durham, NC
License number
North Carolina 17133
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2100 Erwin Rd, Durham, NC 27710
Phone
(919) 620-4467
Personal information
See more information about ANDREW HUANG at radaris.comName
Address
Phone
4841 Moriah Hill Rd, Durham, NC 27707
106 Glenmore Rd, Chapel Hill, NC 27516
205 Crowne Club Dr APT 9, Winston Salem, NC 27104
4841 Moriah Hill Rd, Durham, NC 27707
Organization information
See more information about ANDREW HUANG at bizstanding.comAndrew Huang MD
2100 Erwin Rd, Durham, NC 27705
Industry:
Internist
Phone:
(919) 620-4467 (Phone)
Andrew Ta-Fu Huang
Professional information
Dr. Andrew Huang, Durham NC - MD (Doctor of Medicine)
Specialties:
Hematology, Hematology & Oncology
Address:
2100 Erwin Rd, Durham 27705
(919) 620-4467 (Phone)
2100 Erwin Rd, Durham 27705
(919) 620-4467 (Phone)
2100 Erwin Rd, Durham 27705
Languages:
English
Andrew Huang, Durham NC
Specialties:
Hematologist
Address:
2100 Erwin Rd, Durham, NC 27705
Universal Reference Standard For Normalization Of Microarray Gene Expression Profiling Data
US Patent:
2006013, Jun 22, 2006
Filed:
Mar 28, 2005
Appl. No.:
11/090294
Inventors:
Kuo-Jang Kao - Gainesville FL, US
Hsun-Chih Kuo - Taipei, TW
Andrew Huang - Durham NC, US
Hsun-Chih Kuo - Taipei, TW
Andrew Huang - Durham NC, US
International Classification:
G06F 19/00
US Classification:
702020000
Abstract:
A method of normalizing gene expression data obtained on a given microarray for a particular biological samples, comprising sorting said data as a function of expression degree for each gene, sorting a reference standard of gene expression data according to the same function of expression degree, and normalizing the expression degree of said particular gene expression data to the corresponding value in the reference standard, the reference standard having been obtained from gene expression data which is other than said particular gene expression data. The method is applicable for normalizing data obtained on a given microarray under varying conditions, including updates in associated instrumentation.
Methods And Agents For The Diagnosis And Treatment Of Hepatocellular Carcinoma
US Patent:
2011008, Apr 14, 2011
Filed:
Mar 18, 2009
Appl. No.:
12/933248
Inventors:
Kuo-Jang Kao - Gainesville FL, US
Andrew T. Huang - Durham NC, US
Andrew T. Huang - Durham NC, US
International Classification:
A61K 51/00, A61K 39/395, C12Q 1/68, C07K 16/00
US Classification:
424 149, 4241391, 435 6, 5303879, 4241331, 4241781, 5303873, 5303913
Abstract:
The present invention relates to methods of diagnosing, and methods of treating, hepatocellular carcinoma in a subject. The invention also relates to antagonists of PLVAP proteins, such as antibodies that specifically bind PLVAP proteins, as well as compositions and kits comprising antagonists of PLVAP proteins. The invention further relates to humanized antibodies that specifically bind PLVAP protein.
Methods, Agents And Kits For The Detection Of Cancer
US Patent:
2011015, Jun 30, 2011
Filed:
Apr 8, 2009
Appl. No.:
12/937207
Inventors:
Kuo-Jang Kao - Gainesville FL, US
Ta-Yuan Chen - Taiwan, CN
To-Yu Huang - Taiwan, CN
Andrew T. Huang - Durham NC, US
Ta-Yuan Chen - Taiwan, CN
To-Yu Huang - Taiwan, CN
Andrew T. Huang - Durham NC, US
Assignee:
China Synthetic Rubber Corporation - Taipei , TAIWAN
International Classification:
C12Q 1/68
US Classification:
435 612
Abstract:
The present invention relates to methods of diagnosing a cancer in a subject, and methods of providing a prognosis for a subject that has a cancer. The invention also relates to diagnostic and prognostic kits for cancer.
Methods For Classifying And Treating Breast Cancers
US Patent:
2011021, Sep 8, 2011
Filed:
Mar 3, 2011
Appl. No.:
13/040042
Inventors:
Kuo-Jang Kao - Gainesville FL, US
Kai-Ming Chang - Taichung, TW
Andrew T. Huang - Durham NC, US
Kai-Ming Chang - Taichung, TW
Andrew T. Huang - Durham NC, US
International Classification:
A61K 39/395, C40B 30/00, A61K 31/519, A61K 31/704, A61K 31/138, G01N 33/50, A61P 35/00
US Classification:
4241331, 506 7, 514249, 514 34, 514651, 436 64
Abstract:
The present invention relates to methods of treating a breast cancer in a subject, methods of identifying a subject with a breast cancer as a candidate for a therapy having efficacy for treating a breast cancer molecular subtype, and methods of selecting a therapy for a subject with a breast cancer. The methods comprise determining the molecular subtype of the breast cancer in the subject. In some embodiments, the methods further comprise administering to the subject a therapy that is effective for treating the molecular subtype of the breast cancer.
Methods And Agents For The Diagnosis And Treatment Of Hepatocellular Carcinoma
US Patent:
2011026, Oct 27, 2011
Filed:
Sep 9, 2009
Appl. No.:
13/126734
Inventors:
Kuo-Jang Kao - Gainesville FL, US
Andrew T. Huang - Durham NC, US
Andrew T. Huang - Durham NC, US
International Classification:
A61K 51/10, A61P 35/00, C07K 16/18, C12N 5/18, A61K 39/395
US Classification:
424 149, 435332, 4241391, 5303879, 5303873, 5303913, 4241781
Abstract:
The present invention relates to methods of diagnosing, and methods of treating, hepatocellular carcinoma in a subject. The invention also relates to polypeptide antagonists of PLVAP proteins, including humanized and chimeric antibodies that specifically bind PLVAP proteins, as well as compositions and kits comprising such polypeptide antagonists.
Gene Expression Profiling For Identification Of Prognostic Subclasses In Nasopharyngeal Carcinomas
US Patent:
7998674, Aug 16, 2011
Filed:
Sep 22, 2006
Appl. No.:
12/067549
Inventors:
Kuo-jang Kao - Gainesville FL, US
Andrew Huang - Durham NC, US
Andrew Huang - Durham NC, US
Assignee:
China Synthetic Rubber Corporation - Taipei
International Classification:
C12Q 1/68, C12N 15/12
US Classification:
435 6, 536 235
Abstract:
mRNA transcript profiling can be used to formulate molecular predictors of distant metastasis for primary NPCs. The predicted results are highly correlated with short metastasis-free and overall survival. Predictions are made using 52-genes based and 12-genes based predictors.